InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,444.00
(
2.16%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
-1.03%
)
Bitcoin
62,889.25
(
6.37%
)
Post# of 220778
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

davidsson10

Send PM Follow Ignore
Followers 195
Posts 11276
Boards Moderated 0
Alias Born 11/29/2007

davidsson10

Re: None

Monday, 04/22/2024 5:47:53 AM

Monday, April 22, 2024 5:47:53 AM

Post# of 220778
Biotech Has Been A Tough Nut To Crack Lately

Post-pandemic, the capital markets have been uniquely and historically adverse for biotech.

Historically it's been the bread and butter of much trading activity:

- The Biotech XBI index decreased for three consecutive years

- Of the over 40 companies that went public in the second half of 2021, only two are trading
positively and the majority have decreased more than 80% from their IPO price

- Overall, IPO proceeds dropped by 93% from 2021 to 2022
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up